FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sumatriptan (Sumavel DosePro) Injection
Status: Discontinuation
»Therapeutic Categories:

Endo Pharmaceuticals, Inc. (New 10/17/2016)

Company Contact Information:
800-462-3636

Presentation Posting Date Related Information
Sumavel DosePro (sumatriptan injection) 4mg/0.5mL (NDC 63481-229-06) 10/17/2016 A business decision has been made to discontinue Sumavel DosePro 4 mg/0.5mL. This decision is not related to quality, safety or efficacy concerns. Sumavel DosePro 6mg/0.5mL will remain available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English